Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Price:
37.94 USD
3.32%
Market Closed
Updated:
May 29, 2024
Biohaven Pharmaceutical Holding Company Ltd
Net Change in Cash
|
Biohaven Pharmaceutical Holding Company Ltd
Net Change in Cash Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
|
Net Change in Cash
$9.5m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$11.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
-$218m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$126.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biohaven Pharmaceutical Holding Company Ltd's Net Change in Cash?
Net Change in Cash
9.5m
USD
9.5m
USD
Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Net Change in Cash amounts to 9.5m USD.
What is Biohaven Pharmaceutical Holding Company Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-49%
-49%
Over the last year, the Net Change in Cash growth was -94%. The average annual Net Change in Cash growth rates for Biohaven Pharmaceutical Holding Company Ltd have been -49% over the past three years .
You don't have any saved screeners yet
